Is agilon health Inc (AGL) overvalued? · rev $6.06B
agilon health Inc (AGL) is a medical care facilities company listed on US.
This page asks whether agilon health Inc (AGL) looks expensive on cached numbers — not a short thesis.
Latest reported AGL revenue for 2024-12-31 was $6.06B. Net income was -$260.1M. Revenue was up 40.4% from 2023-12-31 to 2024-12-31. AGL currently screens at market cap $1.45B.
AGL currently screens at market cap $1.45B. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next AGL 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the AGL stock page for the full model, not this heading.
Not investment advice.